Fast Moving Consumer GoodsMid capRs 7,684 crRs 14.8 cr traded a day
Close on 2026-08-21
1,146.50
+4.05%
52-week range90% of the way up
808.701,184.45
Market cap
7,684 cr
P/E (TTM)
24.3×
industry 36×
EPS (TTM)
47.20
Revenue YoY
+30.9%
Q1 FY27
Profit YoY
+60.4%
Net margin
3.2%
+0.6pt vs a year ago
Growth trend
+15.2pt
vs last quarter’s YoY
1 month
-2.3%
Below 52w high
3.3%
RSI (14)
50
Daily swing
4.1%
average true range
Volume
2.1×
vs 20-day average
Traded
Rs 15 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
1 week
+8.05%
1 month
−2.28%
3 months
+13.82%
6 months
+23.93%
1 year
+38.95%
The read
written from the numbers on this page
The evidence leans constructive8 supporting, 0 against, 0 worth knowing
Supporting
trading 15% above its 200-day average
sitting at 90% of its 52-week range, with little overhead supply from trapped buyers
up 39% over twelve months
matches trading far more than usual, which has beaten the market by +0.45 points over 20 sessions across 52,251 past signals
3 independent kinds of evidence agree today, which is uncommon
revenue grew 31% year on year in the quarter ending 2026-06-30
net margin has widened from 2.7% to 3.2% across four quarters
priced at 24× earnings against an industry median of 36× — 33% below its peers
Against
nothing the data supports either way
Worth knowing
nothing the data supports either way
What would change this read: a close below 998, its 200-day average; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
How it has performed
price return over each window, measured against zero
What the scans say today
8 of 47 matched on 2026-08-21
INDIAGLYCO matches 8 of the 47 scans today, across 3 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
segments and revenue mix, as the company reports them
INDIAGLYCO reports 4 business segments. The largest is Potable Spirits at 74% of revenue in the quarter ending 2026-06-30.
SegmentRevenueSharevs a year ago
Potable Spirits2,219 cr74.2%—
Bio-based Specialities and Performance Chemicals363 cr12.2%—
Bio-Fuel323 cr10.8%—
Ennature Biopharma83 cr2.8%—
Segment names are the company’s own, taken verbatim from the reportable-segment disclosure in its quarterly XBRL filing. Nothing on this page describes the business in words we wrote.
Valuation against its own history
265 sessions since 2025-08-13
23×
median 27×
32×
now 24×
INDIAGLYCO trades at 24× trailing earnings, below its median of 27× over this window — 10% less expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Other filing filings were typically -0.08pt vs the market over the next 5 sessions (n=12,093)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 31% against the same quarter a year earlier
profit rose 60% year on year
Going against it
net margin narrowed from 3.7% to 3.2%
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · consolidated
2,988
102
97
14.45
3.2%
Q4 FY26
2026-03-31 · consolidated
2,360
99
87
13.64
3.7%
Q3 FY26
2025-12-31 · consolidated
2,551
87
68
10.79
2.6%
Q2 FY26
2025-09-30 · consolidated
2,412
72
65
10.51
2.7%
Q3 FY25
2024-12-31 · consolidated
2,424
58
57
18.35
2.3%
Q2 FY25
2024-09-30 · consolidated
2,144
53
50
16.06
2.3%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+6.5%
Versus 200-day average+14.9%
Below 52-week high-3.2%
Above 52-week low+41.8%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)50.2
Higher closes in last 53 of 5
Six-month return+23.93%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)4.06%
Volume versus 20-day2.1x
Median daily turnoverRs 14.8 cr
Peers
Fast Moving Consumer Goods · 43 classified companies
INDIAGLYCO trades at 24.3× trailing earnings against an industry median of 36.5× across 39 other classified companies in its industry — cheaper than them, by 33%. A multiple is a statement about expectations, not about quality: cheap usually means the market expects less, and it is often right.
largest twelve by market capitalisation. Market cap and P/E need filed financials, so blanks are companies whose filings have not been read yet
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.